|
WO2020143836A1
|
|
Cd73 antibody, preparation method therefor and application thereof
|
|
WO2020114399A1
|
|
Cd47 antibody, preparation method therefor and uses thereof
|
|
WO2020108660A1
|
|
Anti-human tim-3 monoclonal antibody and application thereof
|
|
WO2020108636A1
|
|
Fully humanized anti-gitr antibody and preparation method therefor
|
|
WO2020103836A1
|
|
Ox40 antibody, preparation method thereof and use thereof
|
|
WO2020011275A1
|
|
Sema4d antibody, preparation method therefor and use thereof
|
|
WO2019192493A1
|
|
Anti-human lag-3 monoclonal antibody and use thereof
|
|
WO2019174603A1
|
|
Antibody targeting ctla-4 , preparation method therefor and use thereof
|
|
WO2019096219A1
|
|
Humanized anti-il-13 antibody and preparation method and use thereof
|
|
WO2019091436A1
|
|
4-1bb antibody and preparation method and use thereof
|
|
CN109311988A
|
|
A kind of BlyS antibody and its preparation method and application
|
|
WO2017198148A1
|
|
Il-13 antibody and preparation method and use thereof
|
|
US2021070875A1
|
|
Anti-c5ar antibody and preparation method and use thereof
|
|
CN103565767A
|
|
Ranolazine sustained release tablet core, coated tablet and preparation method of tablet core
|
|
CN102241724A
|
|
Oleanolic acid salt and its preparation method and crystal
|
|
CN102241723A
|
|
Ursolate as well as preparation method and crystal thereof
|
|
CN102234304A
|
|
Ursolic acid salt, preparation method thereof, and crystal thereof
|
|
CN102043892A
|
|
A molding and using method for a bulk drug gastrointestinal absorption prediction BSPK model
|
|
CN101991532A
|
|
Self-microemulsion composition, microemulsion and preparation methods thereof
|
|
CN101987863A
|
|
Oleanolic acid piperazine salt and preparation method thereof
|
